Product Information
OLMESARTAN MEDOXOMIL 5 MG TAB is a generic product labeled by Micro Labs Limited, priced at $0.0575 per EA under NDC 42571020130. Its NADAC has been published 243 times since Feb 9, 2022.
FDA first approved this application on Sep 17, 2019.
Strength
5 mg/1
Manufacturer
Micro Labs LimitedNDC
42571020130
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA206372FDA Approved
9/17/2019
On Market Since
2/3/2020
Pharmacological Classes
Price Statistics
The NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has been published 243 times since Feb 9, 2022, and over the history we have for it it has declined 31.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0575 per EA |
|---|---|
| All-time high | $0.0844 (Sep 11, 2024) |
| All-time low | $0.0551 (Aug 19, 2026) |
| 52-week high | $0.0593 |
| 52-week low | $0.0551 |
| Median price | $0.0647 |
| Average price | $0.0647 |
| Largest weekly change | -24.8% (Nov 20, 2024) |
| Weeks tracked | 243 |
| Tracking since | Feb 9, 2022 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Micro Labs Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
olmesartan medoxomil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OLMESARTAN MEDOXOMIL 5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN MEDOXOMIL 5 MG TAB, manufactured by Micro Labs Limited, is $0.0575 per EA (NDC 42571020130), effective Sep 30, 2026.
How has the price of OLMESARTAN MEDOXOMIL 5 MG TAB changed over time?
Over the history we have for it, the NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has declined 31.8%. It has been tracked across 243 weekly CMS publications since Feb 9, 2022.
What are the highest and lowest recorded NADAC prices for OLMESARTAN MEDOXOMIL 5 MG TAB?
Since Feb 9, 2022, the NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has ranged from a low of $0.0551 (Aug 19, 2026) to a high of $0.0844 (Sep 11, 2024), with a median of $0.0647 per EA.
Are there cheaper alternatives to OLMESARTAN MEDOXOMIL 5 MG TAB?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OLMESARTAN MEDOXOMIL 5 MG TAB, is $0.0563 per EA — about 2% below OLMESARTAN MEDOXOMIL 5 MG TAB.
Who manufactures OLMESARTAN MEDOXOMIL 5 MG TAB?
OLMESARTAN MEDOXOMIL 5 MG TAB (NDC 42571020130) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.